- BioLife Solutions, Inc. is a developer, manufacturer, and marketer of bioproduction tools and services for the cell and gene therapy industry.
- BioLife Solutions currently operates one bioproduction tools and services business with various product lines that support the stages of biological material manufacturing and delivery.
- BioLife's bioproduction tools and services cover five key offerings including 1) Biopreservation media; 2) Automated thawing devices; 3) Cloud-connected “smart” shipping containers; 4) Freezer and storage technology and related components; 5) Biological and pharmaceutical material.
- BioLife is operating smoothly with $48.1M in revenue at FYE 2020 (+76% y/y) with $2.7M in net income and cash flow from operations of $7M with management guidance outlining 110% to +129% revenue growth in 2021.
- In summary, the author projects BioLife Solutions, Inc. as a "buy" at a 2-year price target of $56.43/share (+34% upside).
For further details see:
BioLife Solutions: Cryobiology Specialist, Aggressive M&A-Led Triple-Digit-Growth Ahead